CCG 1423
Tocris Bioscience, part of Bio-Techne | Catalog # 5233
Rho/SRF pathway inhibitor; induces intermediate mesoderm differentiation from ESCs
Discontinued Product
5233 has been discontinued.
View all Rho GTPase Inhibitors products.
Key Product Details
Description
Rho/SRF pathway inhibitor; induces intermediate mesoderm differentiation from ESCs
Product Description
CCG 1423 is a Rho/SRF pathway inhibitor; stimulates apoptosis of a melanoma cell line overexpressing RhoC (A375M2). Suppresses Rho-dependent invasion of PC-3 prostate cancer cells in vitro and inhibits lysophosphatidic acid-induced DNA synthesis in PC-3 prostate cancer cells. When used in combination with Retinoic acid, LY 294002 and Pyridone 6, it induces intermediate mesoderm differentiation from ESCs.Product Specifications
Molecular Weight
454.75
Formula
C18H13ClF6N2O3
Storage
Store at +4°C
Purity
≥99% (HPLC)
Chemical Name
N-[2-[(4-Chlorophenyl)amino]-1-methyl-2-oxoethoxy]-3,5-bis(trifluoromethyl)benzamide
CAS Number
285986-88-1
PubChem ID
2726015
InChI Key
DSMXVSGJIDFLKP-UHFFFAOYSA-N
SMILES
O=C(NOC(C)C(NC2=CC=C(Cl)C=C2)=O)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 45.48 | 100 |
Preparing Stock Solutions
for CCG 1423
The following data is based on the product molecular weight 454.75
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 2.20 mL | 11.00 mL | 21.99 mL |
| 5 mM | 0.44 mL | 2.20 mL | 4.40 mL |
| 10 mM | 0.22 mL | 1.10 mL | 2.20 mL |
| 50 mM | 0.04 mL | 0.22 mL | 0.44 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Evelyn CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling. Mol.Cancer Ther. 2007 PMID: 17699722
- Mae Combination of small molecules enhances differentiation of mouse embryonic stem cells into intermediate mesoderm through BMP7-positive cells. Biochem.Biophys.Res.Commun. 2010 PMID: 20171952
Product Specific Notices for CCG 1423
For research use only
Loading...
Loading...